Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients

被引:95
|
作者
Yang, Li-Tao
Peng, Hui
Zhu, Zhao-Ling
Li, Gang
Huang, Zi-Tong
Zhao, Zhi-Xin
Koup, Richard A.
Bailer, Robert T.
Wu, Chang-You
机构
[1] Sun Yat Sen Univ, Zhongshan Med Sch, Dept Immunol, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510630, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 2, Guangzhou 510120, Peoples R China
[4] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
基金
中国国家自然科学基金;
关键词
SARS; SARS-CoV; S protein; IFN-gamma; cellular immune response; memory T cells;
D O I
10.1016/j.clim.2006.05.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of cell-mediated immunity in human SARS-CoV infection is still not welt understood. In this study, we found that memory T-cell responses against the spike (S) protein were persistent for more than I year after SARS-CoV infection by detecting the production of IFN-gamma using ELISA and ELISpot assays. Flow cytometric analysis showed that both CD4(+) and CD8(+) Tcells were involved in cellular responses against SARS-CoV infection. Interestingly, most of SARS-CoV S-specific memory CD4(+) Tcells were central memory cells expressing CD45RO(+) CCR7(+) CD62L(-). However, the majority of memory CD8(+) Tcells revealed effector memory phenotype expressing CD45RO(-) CCR7(-) CD62L(-). Thus, our study provides the evidence that SARS-CoV infection in humans can induce cellular immune response that is persistent for a tong period of time. These data may have an important implication in the possibility of designing effective vaccine against SARS-CoV infection, specifically in defining T-cell populations that are implicated in protective immunity. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:171 / 178
页数:8
相关论文
共 50 条
  • [1] Persistent memory CD4+ (and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen
    Yang, Litao
    Peng, Hui
    Zhu, Zhaoling
    Li, Gang
    Huang, Zitong
    Zhao, Zhixin
    Koup, Richard A.
    Bailer, Robert T.
    Wu, Changyou
    JOURNAL OF GENERAL VIROLOGY, 2007, 88 : 2740 - 2748
  • [2] Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients
    Peng, Hui
    Yang, Li-Tao
    Wang, Ling-yun
    Li, Jian
    Huang, Jun
    Lu, Zhi-qiang
    Koup, Richard A.
    Bailer, Robert T.
    Wu, Chang-you
    VIROLOGY, 2006, 351 (02) : 466 - 475
  • [3] Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV
    Darnell, MER
    Subbarao, K
    Feinstone, SM
    Taylor, DR
    JOURNAL OF VIROLOGICAL METHODS, 2004, 121 (01) : 85 - 91
  • [4] SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS (SARS-CoV) : METHODS OF DIAGNOSIS AND TREATMENT
    Bhargava, Shivanshi
    Singh, Aditi
    EVERYMANS SCIENCE, 2020, 54 (06): : 361 - 367
  • [5] Synthetic peptide studies on severe acute respiratory syndrome coronavirus (SARS-CoV)
    Chu, LHM
    Choy, WY
    Waye, MMY
    Ngai, SM
    FEBS JOURNAL, 2005, 272 : 140 - 141
  • [6] Fusion core structure of the severe acute respiratory syndrome coronavirus (SARS-CoV): In search of potent SARS-CoV entry inhibitors
    Chu, Ling-Hon Matthew
    Chan, Siu-Hong
    Tsai, Sau-Na
    Wang, Yi
    Cheng, Christopher Hon-Ki
    Wong, Kam-Bo
    Waye, Mary Miu-Yee
    Ngai, Sai-Ming
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 104 (06) : 2335 - 2347
  • [7] Prior Immunization with Severe Acute Respiratory Syndrome (SARS)-Associated Coronavirus (SARS-CoV) Nucleocapsid Protein Causes Severe Pneumonia in Mice Infected with SARS-CoV
    Yasui, Fumihiko
    Kai, Chieko
    Kitabatake, Masahiro
    Inoue, Shingo
    Yoneda, Misako
    Yokochi, Shoji
    Kase, Ryoichi
    Sekiguchi, Satoshi
    Morita, Kouichi
    Hishima, Tsunekazu
    Suzuki, Hidenori
    Karamatsu, Katsuo
    Yasutomi, Yasuhiro
    Shida, Hisatoshi
    Kidokoro, Minoru
    Mizuno, Kyosuke
    Matsushima, Kouji
    Kohara, Michinori
    JOURNAL OF IMMUNOLOGY, 2008, 181 (09): : 6337 - 6348
  • [8] Molecular Advances in Severe Acute Respiratory Syndrome-associated Coronavirus (SARS-CoV)
    Raymond Kin Hi Hui
    Raymond Tsz Yeung Wong
    Chi Wai Yip
    Frederick Chi Ching Leung
    Genomics Proteomics & Bioinformatics, 2003, (04) : 247 - 262
  • [9] Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)
    Lee, YS
    Chen, CH
    Chao, A
    Chen, ES
    Wei, ML
    Chen, LK
    Yang, KDD
    Lin, MC
    Wang, YH
    Liu, JW
    Eng, HL
    Chiang, PC
    Wu, TS
    Tsao, KC
    Huang, CG
    Tien, YJ
    Wang, TH
    Wang, HS
    Lee, YS
    BMC GENOMICS, 2005, 6 (1)
  • [10] Molecular signature of clinical severity in recovering patients with severe acute respiratory syndrome coronavirus (SARS-CoV)
    Yun-Shien Lee
    Chun-Houh Chen
    Angel Chao
    En-Shih Chen
    Min-Li Wei
    Lung-Kun Chen
    Kuender D Yang
    Meng-Chih Lin
    Yi-Hsi Wang
    Jien-Wei Liu
    Hock-Liew Eng
    Ping-Cherng Chiang
    Ting-Shu Wu
    Kuo-Chein Tsao
    Chung-Guei Huang
    Yin-Jing Tien
    Tzu-Hao Wang
    Hsing-Shih Wang
    Ying-Shiung Lee
    BMC Genomics, 6